Omniox

Omniox is an IND-stage biotherapeutics company developing OMX as a broad-acting cancer immunotherapy. OMX is engineered to deliver oxygen safely into hypoxic, immunosuppressive tumor microenvironments. By specifically oxygenating immunosuppressed cancers, OMX restores local immune responses with the potential for patient cures.